MAPT and Alzheimer disease: Current pathological hypotheses of AD include, but are not restricted to, reductions in choline acetyltransferase, glutamate excitotoxicity, amyloid beta (Aβ) aggregation, tau phosphorylation, brain insulin resistance [7], and gut microbiome alterations [8].